Squalene
IUPAC name	(6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene
Identifiers
CAS number	111-02-4 Y
SMILES	C\C(C)=C\CCC(\C)=C\CCC(\C)=C\CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C
InChI	1/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24+
Properties
Molecular formula	C30H50
Molar mass	410.72 g mol−1
Density	0.855 g/cm3
Melting point	-100 °C
Boiling point	285 °C at 25 mmHg
Y (what is this?)  (verify) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Squalene is a natural organic compound originally obtained for commercial purposes primarily from shark liver oil, though plant sources (primarily vegetable oils) are used as well, including amaranth seed, rice bran, wheat germ, and olives. All higher organisms produce squalene, including humans. Squalene has been proposed to be a important part of the Mediterranean diet as it may be a chemopreventative substance that protects people from cancer.^[1][2]

Squalene is a hydrocarbon and a triterpene, and is a natural and vital part of the synthesis of cholesterol, steroid hormones, and vitamin D in the human body.^[3] Squalene is used in cosmetics, and more recently as an immunologic adjuvant in vaccines.

[edit] Role in steroid synthesis

Squalene is the biochemical precursor to the whole family of steroids.^[4] Oxidation (via squalene monooxygenase) of one of the terminal double bonds of squalene yields 2,3-squalene oxide, which undergoes enzyme-catalyzed cyclization to afford lanosterol, which is then elaborated into cholesterol and other steroids.

Simplified version of the steroid synthesis pathway with the intermediates isopentenyl pyrophosphate (IPP), dimethylallyl pyrophosphate (DMAPP), geranyl pyrophosphate (GPP) and squalene shown. Some intermediates are omitted.

[edit] Biosynthesis

• Two molecules of farnesyl pyrophosphate condense with reduction by NADPH to form squalene - by squalene synthase.

[edit] Shark squalene

Squalene is a low density compound often stored in the bodies of cartilaginous fish such as sharks, which lack a swim bladder and must therefore reduce their body density with fats and oils. Squalene, which is stored mainly in the shark's liver, is lighter than water with a specific gravity of 0.855. Recently it has become a trend for sharks to be hunted to process their livers for the purpose of making squalene health capsules. Environmental and other concerns over shark hunting have motivated its extraction from vegetable sources instead.^[5]

[edit] Use as a skin moisturizer in cosmetics

Squalene is used in cosmetics as a natural moisturizer. It penetrates the skin quickly, does not leave a greasy feeling on the skin and blends well with other oils and vitamins. Squalane is a saturated form of squalene in which the double bonds have been eliminated by hydrogenation. Because squalane is less susceptible to oxidation than squalene, it is more commonly used in personal care products. Toxicology studies have determined that in the concentrations used in cosmetics, both squalene and squalane have low acute toxicity, and are not significant human skin irritants or sensitizers.^[6]

[edit] Use as an adjuvant in vaccines

Immunologic adjuvants are substances, administered in conjunction with a vaccine, that stimulate the immune system and increase the response to the vaccine. Squalene is one of those adjuvants.^[7] It is added to improve the efficacy of several vaccines, including pandemic flu and malaria vaccines. This includes several European countries, which use these formulations in their 2009 flu pandemic vaccines.^[8]

An adjuvant using squalene is Novartis' proprietary adjuvant MF59, which is added to influenza vaccines to help stimulate the human body's immune response through production of CD4 memory cells. It is the first oil-in-water influenza vaccine adjuvant to be commercialized in combination with a seasonal influenza virus vaccine. It was developed in the 1990s by researchers at Ciba-Geigy and Chiron; both companies were subsequently acquired by Novartis.^[9] It is present in the form of an emulsion and is added to make the vaccine more immunogenic.^[10] An MF59-adjuvanted influenza vaccine (Fluad, developed by Chiron, which contains about 10 mg of squalene per dose) has been approved by health agencies and used in several European countries for seasonal flu shots since 1997.^[7] However, the Food and Drug Administration has not authorized the use of such adjuvants in the United States.^[11] Glaxo Smith Kline used the squalene-based AS03 adjuvant in their 2009 influenza pandemic vaccine Pandemrix and Arepanrix.

A 2009 meta-analysis by researchers at Novartis Vaccines and Diagnostics that was published in the journal Vaccine brought together data from 64 clinical trials of influenza vaccines with the squalene-containing adjuvant MF59 and compared them to the effects of vaccines with no adjuvant. The analysis reported that the adjuvanted vaccines were associated with slightly lower risks of chronic diseases, but that neither type of vaccines altered the rate of autoimmune diseases; the authors concluded that their data "supports the good safety profile associated with MF59-adjuvanted influenza vaccines and suggests there may be a clinical benefit over non-MF59-containing vaccines".^[12]

[edit] Health controversy

There have been attempts to link squalene to Gulf War Syndrome mainly due to the idea that squalene might have been present in an anthrax vaccine given to some military personnel during the 1991 Persian Gulf War. One study found that deployed Persian Gulf War Syndrome patients are significantly more likely to have antibodies to squalene (95 percent) than asymptomatic Gulf War veterans (0 percent; p<.001);^[13] however, the study concludes with the following statement: "It is important to note that our laboratory-based investigations do not establish that squalene was added as adjuvant to any vaccine used in military or other personnel who served in the Persian Gulf War era." However, a committee of the US Institute of Medicine stated that "The committee does not regard this study as providing evidence that the investigators have successfully measured antibodies to squalene", since the authors did not perform the normal scientific controls needed show that their test was specific to anti-squalene antibodies.^[14] It has also been determined that the anthrax vaccines given to those US military personnel did not use squalene as an adjuvant.^[15][16][17] The vaccines were also tested for squalene, and none was detected with standard methods.^[18] A much more sensitive method was then developed, which again found no squalene in 37 of the 38 lots tested. One lot contained traces of squalene, at less than ten parts per billion, which is about 30-fold less than the level found in human blood.^[19] The FDA stated that this trace of squalene probably came from a fingerprint, since the oils on human skin contain enough squalene to send these extremely sensitive tests "off the chart".^[20]

A later study reported that about one in ten people have squalene antibodies in their blood, regardless of whether or not they received squalene from a vaccination.^[21] A later study confirmed this result, and also showed that vaccination with squalene-containing vaccines do not alter the levels of these naturally-occurring antibodies.^[15] A third study showed that these naturally-occurring antibodies were no more common in Gulf war veterans than in the general population.^[22]

Oil-water suspensions, including MF59, were associated with the ability to induce lupus autoantibodies in non-autoimmune mice.^[23] In one study, endogenous squalene was linked to autoimmune arthritis in rats.^[24] An epidemiologic analysis of safety data on MF59 seasonal and pandemic influenza vaccines showed no evidence of increased risk of vaccine adverse events of potential autoimmune origin.^[25]

The World Health Organization and the US Department of Defense have both published extensive reports that emphasize that squalene is a chemical naturally occurring in the human body, present even in oils of human fingerprints.^[26][10] WHO goes further to explain that squalene has been present in over 22 million flu vaccines given to patients in Europe since 1997 and there have never been significant vaccine-related adverse events.^[10]

[edit] References